Gemcitabine and Dasatinib in Advanced Solid Tumors

NCT00429234 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer
Solid Tumors

Interventions

DRUG: Dasatinib
DRUG: Gemcitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]